Skip to main content
SpringerLink
Log in

Enprostil: Syntex' prostaglandin derivative has been approved for marketing in France, its first major market (references since issue 481)

  • Newsletter Article
  • Published:
InPharma

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Enprostil: Syntex' prostaglandin derivative has been approved for marketing in France, its first major market (references since issue 481). Inpharma Wkly. 596, 20 (1987). https://doi.org/10.1007/BF03306267

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03306267

Keywords

Search

Navigation